These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 7846538

  • 1. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update.
    Ettinger DS.
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538
    [Abstract] [Full Text] [Related]

  • 2. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K, Wolf M, Drings P, Hans K, Schroeder M, Holle R, Flechtner H, Goerg R, Becker H.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [Abstract] [Full Text] [Related]

  • 3. The role of ifosfamide in small cell lung cancer.
    Loehrer PJ.
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
    [Abstract] [Full Text] [Related]

  • 4. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [Abstract] [Full Text] [Related]

  • 5. Ifosfamide in small cell lung cancer.
    Einhorn LH.
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):19-21. PubMed ID: 2539644
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer.
    Lorigan P, Lee SM, Betticher D, Woodhead M, Weir D, Hanley S, Hardy C, Thatcher N.
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):32-41. PubMed ID: 7610397
    [Abstract] [Full Text] [Related]

  • 7. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 8. Management of small cell lung cancer in elderly.
    Satoh H, Ishikawa H, Funayama Y, Yamashita YT, Kamma H, Ohtsuka M, Sekizawa K.
    Anticancer Res; 1999 Jun; 19(5C):4507-10. PubMed ID: 10650801
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 10. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000 Nov 27; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 11. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Sandler AB.
    Semin Oncol; 1998 Feb 27; 25(1 Suppl 2):38-41. PubMed ID: 9535210
    [Abstract] [Full Text] [Related]

  • 12. Ifosfamide, doxorubicin, vincristine, and etoposide in small cell lung cancer.
    Elisson LO, Ekberg L.
    Semin Oncol; 1995 Feb 27; 22(1 Suppl 2):15-7. PubMed ID: 7846536
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Li DX, Chen XB.
    Ai Zheng; 2002 Apr 27; 21(4):412-5. PubMed ID: 12452023
    [Abstract] [Full Text] [Related]

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 27; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 15. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Herbst R, Leong T, Lynch C, Kwiatkowski DJ, Carey RW, Grossbard ML, Skarin AT.
    Semin Oncol; 1997 Aug 27; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [Abstract] [Full Text] [Related]

  • 16. Intensive combined-modality therapy in small cell lung cancer.
    Thatcher N, Lorrigan P, Burt P, Stout R.
    Semin Oncol; 1994 Jun 27; 21(3 Suppl 6):9-22. PubMed ID: 8052879
    [Abstract] [Full Text] [Related]

  • 17. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S, Pampallona S, Martinelli G, Ploner F, Perey L, Aversa S, Peters S, Brunsvig P, Montes A, Lange A, Yilmaz U, Rosti G, Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
    J Natl Cancer Inst; 2008 Apr 16; 100(8):533-41. PubMed ID: 18398095
    [Abstract] [Full Text] [Related]

  • 18. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
    Ettinger DS, Finkelstein DM, Ritch PS, Lincoln ST, Blum RH, Eastern Cooperative Oncology Group.
    Lung Cancer; 2002 Sep 16; 37(3):311-8. PubMed ID: 12234701
    [Abstract] [Full Text] [Related]

  • 19. Hoosier Oncology Group studies in extensive and recurrent small cell lung cancer.
    Einhorn LH, Loehrer PJ.
    Semin Oncol; 1995 Feb 16; 22(1 Suppl 2):28-31. PubMed ID: 7846539
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
    Kosmidis PA, Samantas E, Fountzilas G, Pavlidis N, Apostolopoulou F, Skarlos D.
    Semin Oncol; 1994 Jun 16; 21(3 Suppl 6):23-30. PubMed ID: 8052870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.